Recent Progress in Heart Failure Treatment and Heart Transplantation

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 23, Issue 5, 2009, Pages 738-748

  Augoustides, John G T ^a   Riha, Hynek ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

Author keywords

cardiac resynchronization; heart failure; heart transplantation; heparin induced thrombocytopenia; immunosuppression; pulmonary embolism; pulmonary hypertension; relaxin; surgical ventricular restoration; tumor necrosis factor; ventricular assist device

Indexed keywords

ALDOSTERONE ANTAGONIST; ANGIOTENSIN ANTAGONIST; CYCLOSPORIN; DOBUTAMINE; DOPAMINE; GLYCERYL TRINITRATE; HEPARIN; HYDRALAZINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 2 BLOCKING AGENT; MILRINONE; MYCOPHENOLIC ACID; NESIRITIDE; NITRIC ACID DERIVATIVE; NITROPRUSSIDE SODIUM; RELAXIN; SILDENAFIL; TACROLIMUS; UNCLASSIFIED DRUG;

ANTICOAGULATION; BETA ADRENERGIC RECEPTOR BLOCKING; CARDIAC RESYNCHRONIZATION THERAPY; CORONARY ARTERY BYPASS SURGERY; DEFIBRILLATOR; DISEASE COURSE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART MUSCLE ISCHEMIA; HEART SURGERY; HEART TRANSPLANTATION; HEPARINIZATION; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; LUNG EMBOLISM; MEDICAL PRACTICE; MORTALITY; NEUROLOGIC DISEASE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; REVIEW; RISK ASSESSMENT; SCORING SYSTEM; SOCIAL PSYCHOLOGY; THROMBOCYTOPENIA; TREATMENT OUTCOME;

CARDIAC SURGICAL PROCEDURES; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; TREATMENT OUTCOME;

EID: 70349332464     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jvca.2009.06.009     Document Type: Review

References (78)

1. Jessup M., Abraham W.T., Casey D.E., et al. Focused Update: ACC/AHA Guidelines for the diagnosis and management of heart failure in adults. A report of the American College of Cardiology Foundation/American Heat Association task Force on Practice Guidelines. Circulation 119 (2009) 1977-2016
2. Mueller C., Scholer A., Laule-Kilian K., et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 350 (2004) 647-654
3. Tang W.H., Girod J.P., Lee M.J., et al. Plasma B-type natriuretic peptide levels in ambulatory patients with established chronic symptomatic systolic heart failure. Circulation 108 (2003) 2964-2966
4. Siverman M.E., Pressel M.D., Brackett J.C., et al. Prognostic value of the signal-averaged electrocardiogram and a prolonged QRS in ischemic and nonischemic cardiomyopathy. Am J Cardiol 75 (1995) 460-464
5. Serruys P.W., Morice M.-C., Kappetein A.P., et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med 360 (2009) 961-972
6. Eisen H.J. Surgical ventricular reconstruction for heart failure. N Engl J Med 360 (2009) 1781-1784
7. Athanasuleas C.L., Stanley Jr. A.W., Buckberg G.D., et al. Surgical anterior ventricular endocardial restoration (SAVER) in the dilated remodelled ventricle after anterior myocardial infarction. RESTORE Group. Reconstructive endoventricular surgery returning torsion original radius elliptical shape to the LV. J Am Coll Cardiol 37 (2001) 1199-1209
8. Athanasuleas C.L., Buckberg G.D., Stanley A.W., et al., RESTORE Group. Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation. J Am Coll Cardiol 44 (2004) 1439-1445
9. Subramanian H., Kunadian B., and Dunning J. Is it worth performing surgical ventricular restoration in patients with ischemic cardiomyopathy and akinetic but non-aneurysmal segments in the left ventricle?. Interact CardioVasc Thorac Surg 7 (2008) 702-707
10. Jones R.H., Velazquez E.J., Michler R.E., et al. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med 360 (2009) 1705-1717
11. Gheorghiade M., and Pang P.S. Acute heart failure syndromes. J Am Coll Cardiol 53 (2009) 557-573
12. Teichman S.L., Unemori E., Dscietzig T., et al. Relaxin, a pleiotropic vasodilator for the treatment of heart failure. Heart Fail Rev (2008 Dec 20) [Epub ahead of print]
13. Dschietzig T., Teichman S.L., Unemori E., et al. Intravenous recombinant human relaxin in compensated heart failure: A safety, tolerability and pharmacodynamic trial. J Cardiac Fail 15 (2009) 182-190
14. Teerlink J.R., Metra M., Felker G.M., et al. Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): A multicentre, randomized, placebo-controlled, parallel-group, dose-finding phase IIb study. Lancet 373 (2009) 1429-1439
15. Winkles J.A. The TWEAK-Fn 14 cytokine-receptor axis: Discovery, biology, and therapeutic targeting. Nat Rev Drug Discov 7 (2008) 411-425
16. Jain M., Jakubowski A., Cui L., et al. A novel role for tumor necrosis factor like weak inducer of apoptosis (TWEAK) in the development of cardiac dysfunction and failure. Circulation 119 (2009) 2058-2068
17. Paulus W.J., Tschope C., Sanderson J.E., et al. How to diagnose heart failure: A consensus statement on the diagnosis of heart failure with normal left ventricular fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 28 (2007) 2539-2550
18. Kuznetsova T., Herbots L., Lopez B., et al. Prevalence of left ventricular diastolic dysfunction in a general population. Circ Heart Fail 2 (2009) 105-112
19. Brislow M.R., Saxon L.A., Boehmer J., et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 350 (2004) 2140-2150
20. Anand I.S., Carson P., Galle E., et al. Cardiac resynchronization therapy reduces the risk of hospitalizations in patients with advanced heart failure: Results from the comparison of medical therapy, pacing and defibrillation in heart failure (COMPANION) trial. Circulation 119 (2009) 969-977
21. POISE Study Group. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): A randomized controlled trial. Lancet 371 (2008) 1839-1847
22. London M.J., Zaugg M., Schaub M.C., et al. Perioperative beta-adrenergic receptor blockade: Physiologic foundations and clinical controversies. Anesthesiology 100 (2004) 170-175
23. Sidi A., Muehlschlegel J.D., Kirby D.S., et al. Treatment of ischaemic left ventricular dysfunction with milrinone or dobutamine administered during coronary artery stenosis in the presence of beta blockade in pigs. Br J Anaesth 97 (2006) 799-807
24. Sutner S., Boldt J., Mengistu A., et al. Influence of continuous perioperative beta-blockade in combination with phosphodiesterase inhibition on haemodynamics and myocardial ischaemia in high-risk vascular surgery patients. Br J Anaesth 102 (2009) 597-607
25. Peberdy M.A., Omato J.P., Larkin G.L., et al. Survival from in-hospital cardiac arrest during nights and weekends. JAMA 299 (2008) 785-792
26. Fonarow G.C., Abraham W.E., Albert N.M., et al. Day of admission and clinical outcomes for patients hospitalized with heart failure: Findings from the Organized Program to Initiate Lifesaving Treatment in Hospitalized patients with Heart Failure (OPTIMIZE-HF). Circ Heart Fail 1 (2008) 50-57
27. Aujesky D., Jimenez D., Mor M.K., et al. Weekend versus weekday admission and mortality after acute pulmonary embolism. Circulation 119 (2009) 962-968
28. Gustafsson F., Torp-Pedersen C., Brendorp B., et al. Long-term survival in patients hospitalized with congestive heart failure: relation to preserved and reduced left ventricular systolic function. Eur Heart J 24 (2003) 863-870
29. Ngaage D.L., Cowen M.E., and Cale A.R. Cardiopulmonary bypass and left ventricular systolic dysfunction impacts operative mortality differently in elderly and young patients. Eur J Cardiothorac Surg 35 (2009) 235-240
30. Wilson S.R., Mudge G.H., Stewart G.C., et al. Evaluation for a ventricular assist device: Selecting the appropriate candidate. Circulation 119 (2009) 2225-2232
31. Rosamond W., Flegal K., Furie K., et al. Heart disease and stroke statistics: 2008 update: A report from the American heart Association Statistics Committee and the Stroke Statistics Subcommittee. Circulation 117 (2008) e25-e146
32. Lietz K., Long J.W., Kfoury A.G., et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: Implications for patient selection. Circulation 116 (2007) 497-505
33. Kirklin J.K., Naftel D.C., Stevenson L.W., et al. INTERMACS database for durable devices for circulatory support: First annual report. J Heart Lung Transplant 27 (2008) 1065-1072
34. Stevenson L.W., and Couper G. On the fledgling field of mechanical circulatory support. J Am Coll Cardiol 50 (2007) 748-751
35. Holman W.L., Kormos R.L., Naftel D.C., et al. Predictors of death and transplant in patients with a mechanical circulatory support device: A multi-institutional study. J Heart Lung Transplant 28 (2009) 44-50
36. Matthews J.C., Koelling T.M., Pagani F.D., et al. The right ventricular failure risk score: A preoperative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 51 (2008) 2163-2172
37. Fitzpatrick III J.R., Frederick J.R., Hsu V.M., et al. Risk score derived from preoperative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant 27 (2008) 1286-1292
38. Fitzpatrick J.R., Frederick J.R., Hiesinger W., et al. Early planned institution of biventricular mechanical circulatory support results in improved outcomes as compared with delayed conversion of a left ventricular assist device to a biventricular assist device. J Thorac Cardiovasc Surg 137 (2009) 971-977
39. Matsumoto S., Nakahara I., Higashi T., et al. Near-infrared spectroscopy in carotid artery stenting predicts cerebral hyperperfusion syndrome. Neurology 72 (2009) 1512-1518
40. Lietz K., Brown K., Ali S.S., et al. The role of cerebral hyperperfusion in postoperative neurologic dysfunction after left ventricular assist device implantation for end-stage heart failure. J Thorac Cardiovasc Surg 137 (2009) 1012-1019
41. Butler J., Geisberg C., Howser R., et al. Relationship between renal function and left ventricular assist device use. Ann Thorac Surg 81 (2006) 1745-1751
42. Sandner S.E., Zimpfer D., Zrunek P., et al. Renal function and outcome after continuous flow left ventricular assist device implantation. Ann Thorac Surg 87 (2009) 1072-1078
43. Kamdar F., Boyle A., Liao K., et al. Effects of centrifugal, axial, and pulsatile left ventricular assist device support on end-organ function in heart failure patients. J Heart Lung Transplant 28 (2009) 352-359
44. Warkentin T.E., Greinacher A., Koster A., et al. Heparin-induced thrombocytopenia in patients with ventricular assist devices: Are new prevention strategies required?. Ann Thorac Surg 87 (2009) 1633-1640
45. Greinacher A., Eichler P., Lietz T., et al. Replacement of unfractionated heparin by low-molecular-weight heparin for postorthopedic surgery antithrombotic prophylaxis lowers the overall risk of symptomatic thrombosis because of a lower frequency of heparin-induced thrombocytopenia. Blood 106 (2005) 2921-2922
46. Schenk S., El-Banayosy A., Prohaska W., et al. Heparin-induced thrombocytopenia in patients receiving mechanical circulatory support. J Thorac Cardiovasc Surg 131 (2006) 1373-1381
47. Schenk S., El-Banayosy A., Morshuis M., et al. Ig G classification of anti-PF4/heparin antibodies to identify patients with heparin-induced thrombocytopenia during mechanical circulatory support. J Thromb Haemost 5 (2007) 235-241
48. Koster A., Huebler S., Potapov E., et al. Impact of heparin-induced thrombocytopenia on outcome in patients with ventricular assist device support: Single-institution experience in 358 consecutive patients. Ann Thorac Surg 83 (2007) 72-76
49. Crespo F.M., Oliviera G.B., Honeycutt E.F., et al. Evaluation and management of thrombocytopenia and suspected heparin-induced thrombocytopenia in hospitalized patents: The Complications after Thrombocytopenia Caused by Heparin (CATCH) registry. Am Heart J 157 (2009) 651-657
50. Samuels L.E., Kohout J., Casanova-Ghosh E., et al. Argatroban as a primary or secondary postoperative anticoagulant in patients implanted with ventricular assist devices. Ann Thorac Surg 85 (2008) 1651-1655
51. John R., Kamdar F., Liao K., et al. Improved survival and decreasing incidence of adverse events with the HeartMate II ventricular assist device as bridge-to-transplant therapy. Ann Thorac Surg 86 (2008) 1227-1234
52. John R., Kamdar F., Liao K., et al. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device. J Thorac Cardiovasc Surg 136 (2008) 1318-1323
53. Hernandez A.F., Shea A., Milano C.A., et al. Long-term outcomes and costs of ventricular assist devices among medicare beneficiaries. JAMA (2008) 2398-2406
54. Patolla V., Patten R.D., DeNofrio D., et al. The effect of ventricular assist devices on post-transplant mortality: An analysis of the United Network for Organ Sharing Thoracic Registry. J Am Coll Cardiol 53 (2009) 264-271
55. Ramakrishna H., Jaroszewski D.E., and Arabia F.A. Adult cardiac transplantation: A review of perioperative management part 1. Ann Card Anaesth 12 (2009) 71-78
56. Vega J.D., Moore J., Murray S., et al. Heart transplantation in the United States, 1998-2007. Am J Transplant 9 (2009) 932-941
57. Tjang Y.S., Stenlund H., Tenderich G., et al. Pediatric heart transplantation: Current clinical review. J Card Surg 23 (2008) 87-91
58. Barnard C.N. The operation. A human cardiac transplant: An interim report of a successful operation performed at Groote Schuur Hospital, Cape Town. S Afr Med J 41 (1967) 1271-1274
59. Cass M.H., and Brock R. Heart excision and replacement. Guys Hosp Rep 108 (1959) 285-290
60. Lower R.R., and Shumway N.E. Studies on orthotopic homotransplantation of the canine heart. Surg Forum 11 (1960) 18-19
61. Sievers H.H., Weyand M., Kraatz E.G., et al. An alternative technique for orthotopic cardiac transplantation, with preservation of the normal anatomy of the right atrium. Thorac Cardiovasc Surg 39 (1991) 70-72
62. Sarsam M.A., Campbell C.S., Yonan N.A., et al. An alternative surgical technique in orthotopic cardiac transplantation. J Card Surg 8 (1993) 344-349
63. Schnoor M., Schafer T., Luhman D., et al. Bicaval versus standard technique in orthotopic heart transplantation: A systematic review and meta-analysis. J Thorac Cardiovasc Surg 134 (2007) 1322-1331
64. Jacob S., and Sellke F. Is bicaval orthotopic heart transplantation superior to the biatrial technique?. Interact Cardiovasc Thorac Surg (2009 May 8) [Epub ahead of print]
65. Augoustides J.G., and Ochroch E.A. Novel pulmonary vasodilators. Int Anesthesiol Clin 43 (2005) 101-114
66. Augoustides J.G., Culp K., and Smith S. Rebound pulmonary hypertension and cardiogenic shock after withdrawal of inhaled prostacyclin. Anesthesiology 100 (2004) 1023-1025
67. Boffini M., Sansone F., Ceresa F., et al. Role of oral sildenafil in the treatment of right ventricular dysfunction after heart transplantation. Transplant Proc 41 (2009) 1353-1356
68. Ye F., Ying-Bin X., Yu-Guo W., et al. Tacrolimus versus cyclosporine microemulsion for heart transplant recipients: A meta-analysis. J Heart Lung Transplant 28 (2009) 58-66
69. Groetzner J., Kaczmarek I., Schulz U., et al. Mycophenolate and sirolimus as calcineurin-free immunosuppression improves renal function better than calcineurin inhibitor-reduction in late cardiac transplant recipients with chronic renal failure. Transplant 87 (2009) 726-733
70. Raichlin E., Prasad A., Kremers W.K., et al. Sirolimus as primary immunosuppression is associated with improved coronary vasomotor function compared with calcineurin inhibitors in stable cardiac transplant recipients. Eur Heart J 30 (2009) 1356-1363
71. Taylor D.O., Edwards L.B., Boucek M.M., et al. Registry of the International Society for Heart and Lung Transplantation: Twenty-fourth official adult heart transplant report-2007. J Heart Lung Transplant 26 (2007) 769-781
72. Uber P.A., and Mehra M.R. Induction therapy in heart transplantation: Is there a role?. J Heart Lung Transplant 26 (2007) 205-209
73. Moller C.H., Gustafsson F., Gluud C., et al. Interleukin-2 receptor antagonists as induction therapy after heart transplantation: Systematic review with meta-analysis of randomized trials. J Heart Lung Transplant 27 (2008) 835-842
74. Dobbels F., Vanhaecke J., Dupont L., et al. Pretransplant predictors of posttransplant adherence and clinical outcome: An evidence base for pretransplant psychosocial screening. Transplantation 87 (2009) 1497-1504
75. Kristen A.V., Ammon K., Koch A., et al. Return to work after heart transplantation: Discrepancy with subjective work ability. Transplant 87 (2009) 1001-1005
76. Nicolini F., and Gherti T. Alternatives to transplantation in the surgical therapy for heart failure. Eur J Cardiothorac Surg 35 (2009) 214-228
77. Salmons S. Cardiac assistance from skeletal muscle: A reappraisal. Eur J Cardiothorac Surg 35 (2009) 204-213
78. Tendera M., Wojakowski W., Ruzyllo W., et al. Intracoronary infusion of bone marrow-derived elected CD 34 CXCR4 cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: Results of randomized multicenter Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial. Eur Heart J 30 (2009) 1313-1321